All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

146

Reset

146 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • TelitaciceptRC18, RC18-LPhase 38 trials

    RemeGen Co., Ltd. · CTD-ILD, Primary Sjogren's Disease, Sjögren's Disease

  • siRNAADX-038, ADX-324Phase 37 trials

    ADARx Pharmaceuticals, Inc. · Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1

  • MHB018APhase 36 trials

    Minghui Pharmaceutical (Hangzhou) Ltd · Thyroid Eye Disease (TED), Thyroid Eye Disease, TED, Thyroid Associated Ophthalmopathies

  • 4D-1503E10 vg, eyePhase 35 trials

    4D Molecular Therapeutics · Neovascular Age-Related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration

  • CemdisiranALN-CC5Phase 35 trials

    Regeneron · Paroxysmal Nocturnal Hemoglobinuria, Generalized Myasthenia Gravis, Age-related Macular Degeneration (AMD)

  • NPI-001N-Acetylcysteine AmidePhase 35 trials

    Nacuity Pharmaceuticals, Inc. · Retinitis Pigmentosa (RP), Usher Syndrome, Alzheimer´s Disease

  • TiespectusEYE201, MK-8748Phase 35 trials

    EyeBiotech Ltd. · Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization

  • ALXN2220Phase 34 trials

    AstraZeneca · Transthyretin Amyloid Cardiomyopathy (ATTR-CM), Transthyretin Amyloid Cardiomyopathy, Amyloid Transthyretin Cardiomyopathy

  • EYP-1901Phase 34 trials

    EyePoint Pharmaceuticals, Inc. · Diabetic Macular Edema, DME, Diabetic Macular Edema (DME)

  • OLN324Phase 34 trials

    Ollin Biosciences, Inc. · Diabetic Macular Edema (DME), Wet Age Related Macular Degeneration, Wet Age-related Macular Degeneration

  • PRL3-ZUMABPhase 34 trials

    Intra-IMMUSG Pte Ltd · Advanced Malignant Solid Tumor, Solid Tumor, Advanced Solid Cancers

  • ALK-001C20-D3-Retinyl Acetate, C20 Deuterated vitamin APhase 33 trials

    Alkeus Pharmaceuticals, Inc. · Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy

  • SpyGlass Pharma, Inc. · Cataract, Glaucoma, Ocular Hypertension

  • NNC6019-0001Phase 33 trials

    Novo Nordisk · Transthyretin Amyloid Cardiomyopathy (ATTR CM)

  • OTX-TKIaxitinib implantPhase 33 trials

    Ocular Therapeutix, Inc. · Neovascular Age-related Macular Degeneration, Neovascular Age-Related Macular Degeneration, Neovascular Age-Related Macular Degeneration (nAMD)

  • RemigromigEYE103, RestoretPhase 33 trials

    EyeBiotech Ltd. · Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO)

  • Timolol eye drops 0.5%Phase 33 trials

    Glaukos Corporation · Glaucoma, Ocular Hypertension

  • 000 MG01Phase 32 trials

    Inmunotek S.L. · Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic

  • 000 MM09Phase 32 trials

    Inmunotek S.L. · Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic

  • AAV2-hRPE65v2voretigene neparvovec-rzylPhase 32 trials

    Roche (Genentech) · Leber Congenital Amaurosis, Inherited Retinal Dystrophy Due to RPE65 Mutations

  • AGTC-501rAAV2tYF-GRK1-hRPGRco, and modified corticosteroidPhase 32 trials

    Beacon Therapeutics · X-Linked Retinitis Pigmentosa

  • AU-011Bel-sarPhase 32 trials

    Aura Biosciences · Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma

  • BAT5906Phase 32 trials

    Bio-Thera Solutions · Diabetic Macular Edema (DME), Neovascular (Wet) Age-related Macular Degeneration

  • d-MAPPSPhase 32 trials

    Regenerative Ocular Immunobiologics LLC · oGVHD, Ocular Graft Versus Host Disease, oGHVD

  • DFL24498Phase 32 trials

    Dompé Farmaceutici S.p.A · Dry Eye Disease (DED), Atopic Keratoconjunctivitis

  • DSPPhase 32 trials

    Dompé Farmaceutici S.p.A · Atopic Keratoconjunctivitis, Ataxia Telangiectasia

  • EP-088_MM09Phase 32 trials

    Inmunotek S.L. · Allergic Rhinitis, Allergic Rhinoconjunctivitis, Allergic Asthma

  • Gen 2 Travoprost Intracameral ImplantGen 2 Travoprost Intraocular ImplantPhase 32 trials

    Glaukos Corporation · Glaucoma

  • IBI302Phase 32 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Neovascular Age-related Macular Degeneration, Diabetic Macular Oedema

  • Inactive controlQLS-111 vehiclePhase 32 trials

    Can-Fite BioPharma · Hepatocellular Carcinoma, Cirrhosis, Open-angle Glaucoma (OAG)

  • IRX-101Phase 32 trials

    iRenix Medical, Inc. · Retinal Disease

  • JNJ-81201887AAVCAGsCD59Phase 32 trials

    Johnson & Johnson (Janssen) · Geographic Atrophy, Macular Degeneration

  • KSI-101tabirafuspPhase 32 trials

    Kodiak Sciences Inc · Macular Edema Secondary to Inflammation

  • linsitinibPhase 32 trials

    Sling Therapeutics, Inc. · Graves Orbitopathy, Thyroid Eye Disease, TED, Thyroid Eye Disease

  • NCX 470NCX 470 0.1%Phase 32 trials

    Nicox Ophthalmics, Inc. · Open Angle Glaucoma, Ocular Hypertension

  • NucresiranALN-TTRSC04Phase 32 trials

    Alnylam Pharmaceuticals · Transthyretin Amyloidosis With Cardiomyopathy, Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy, hATTR-PN

  • OCS-01Phase 32 trials

    Oculis · Diabetic Macular Edema

  • phentolamine vehiclePhase 32 trials

    Opus Genetics, Inc · Mesopic Vision, Night Vision Loss, Presbyopia

  • Reference DrugNSAIDsPhase 32 trials

    SANGMYUNG innovation · Retinal Vein Occlusion With Macular Edema, Knee Osteoarthritis

  • REGN1908FreneslerbartPhase 32 trials

    Regeneron · Allergic Conjunctivitis

  • REGN1909MevonlerbartPhase 32 trials

    Regeneron · Allergic Conjunctivitis

  • sepofarsenQR-110Phase 32 trials

    Laboratoires Thea · Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis

  • Surabgene LomparvovecABBV-RGX-314Phase 32 trials

    AbbVie · Diabetic Retinopathy, Neovascular Age-related Macular Degeneration

  • Tabirafusp tedromerKSI-501Phase 32 trials

    Kodiak Sciences Inc · Diabetic Macular Edema (DME), Wet Age-related Macular Degeneration

  • TarcocimabTarcocimab tedromer, KSI-301Phase 32 trials

    Kodiak Sciences Inc · Wet Age-related Macular Degeneration, Diabetic Retinopathy

  • VamikibartRO7200220Phase 32 trials

    Roche (Genentech) · Uveitic Macular Edema

  • VGR-R01Phase 32 trials

    Shanghai Vitalgen BioPharma Co., Ltd. · Bietti Crystalline Dystrophy, Inherited Retinal Diseases

  • VVN461 1.0%Phase 32 trials

    VivaVision Biotech, Inc · Non-infectious Anterior Uveitis, Anterior Uveitis

  • ABBV-444Phase 31 trial

    AbbVie · Dry Eye Disease

  • ABP 938Phase 31 trial

    Amgen · Neovascular Age-related Macular Degeneration, nAMD

Page 1 of 3Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.